Microarray testing can only be performed on an amniocentesis or CVS. These tests are more advanced than NIPT and are capable of looking at chromosomes to find out if any of them are missing a small ...

Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research ...

Key drivers include increasing maternal age, technological innovations, heightened awareness, and a strong healthcare ...

Autism Spectrum Disorder is a complex condition with rising global prevalence. Research indicates it stems from a blend of ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

Natera, Inc. , a global leader in cell-free DNA (cfDNA) and precision medicine, today announced it will expand its Fetal Focus test to cover 20 genes, marking a major advancement in single-gene ...

Early detection saves lives. From cancer and heart disease to reproductive health, learn the essential screenings every woman ...

Considering pregnancy later in life? Find out what “advanced maternal age” really means, the risks to consider and how women ...

Natera Inc. is conducting a study titled ‘EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND).’ The study aims to develop and validate a single-gene Non-Invasive Prenatal ...

The cell-free DNA (cfDNA) blood collection tube market is ripe with opportunities driven by the rise in lifestyle-related disorders, demand for minimally invasive diagnostics, and a surge in cancer ...

Genetic testing during pregnancy helps spot a baby’s risk of inherited disorders or chromosomal abnormalities. This article examines its pros and cons straightforwardly and engagingly. Learn what ...